Meei-Huey Jeng

Summary

Affiliation: University of Virginia
Country: USA

Publications

  1. ncbi request reprint Estrogen receptor expression and function in long-term estrogen-deprived human breast cancer cells
    M H Jeng
    Department of Internal Medicine, University of Virginia Health Sciences Center, Charlottesville 22908, USA
    Endocrinology 139:4164-74. 1998
  2. ncbi request reprint The role of mitogen-activated protein (MAP) kinase in breast cancer
    Richard J Santen
    Department of Medicine, Division of Endocrinology, University of Virginia Health System, P O Box 800379, Charlottesville, VA 22908, USA
    J Steroid Biochem Mol Biol 80:239-56. 2002
  3. ncbi request reprint EphA2 overexpression decreases estrogen dependence and tamoxifen sensitivity
    Ming Lu
    Department of Basic Medical Sciences, Purdue University Cancer Center, West Lafayette, Indiana 47907, USA
    Cancer Res 63:3425-9. 2003
  4. ncbi request reprint Imatinib mesylate (Gleevec) inhibits ovarian cancer cell growth through a mechanism dependent on platelet-derived growth factor receptor alpha and Akt inactivation
    Daniela Matei
    Department of Medicine, Walther Oncology Center, Indiana University Cancer Center, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
    Clin Cancer Res 10:681-90. 2004
  5. ncbi request reprint HOXB13 homeodomain protein suppresses the growth of prostate cancer cells by the negative regulation of T-cell factor 4
    Chaeyong Jung
    Department of Urology, Walther Oncology Center, Indiana University, Indianapolis, Indiana 46202, USA
    Cancer Res 64:3046-51. 2004
  6. ncbi request reprint Targeting prostate cancer with conditionally replicative adenovirus using PSMA enhancer
    Sang Jin Lee
    Department of Urology, Indiana University, Indianapolis, IN 46202, USA
    Mol Ther 10:1051-8. 2004
  7. ncbi request reprint Transcriptional targeting modalities in breast cancer gene therapy using adenovirus vectors controlled by alpha-lactalbumin promoter
    Xiong Li
    Department of Urology, Indiana University School of Medicine, Indianapolis, IN 46202, USA
    Mol Cancer Ther 4:1850-9. 2005
  8. ncbi request reprint Anti-tumor efficacy of a transcriptional replication-competent adenovirus, Ad-OC-E1a, for osteosarcoma pulmonary metastasis
    Xiong Li
    Department of Urology, Indiana University School of Medicine, Indianapolis, IN 46202, USA
    J Gene Med 8:679-89. 2006

Collaborators

  • R J Santen
  • RAKESH F KUMAR
  • Kathy D Miller
  • Wei Yue
  • Daniela E Matei
  • Xiong Li
  • Chaeyong Jung
  • Sang Jin Lee
  • Kyung Hee Bae
  • Chinghai Kao
  • Dale VanderPutten
  • Yan Ping Zhang
  • Thomas A Gardner
  • Ming Lu
  • Hong Ji Zhang
  • You Hong Liu
  • Sudhanshu Raikwar
  • Jie Zhang
  • Edyta Vieth
  • Huanling Gao
  • Gary D Hutchins
  • Ran Sook Kim
  • Chihuei Wang
  • Sang Don Lee
  • Yanping Zhang
  • Hong Sup Kim
  • Thomas Gardner
  • Yesim Gokmen-Polar
  • Michael S Kinch

Detail Information

Publications8

  1. ncbi request reprint Estrogen receptor expression and function in long-term estrogen-deprived human breast cancer cells
    M H Jeng
    Department of Internal Medicine, University of Virginia Health Sciences Center, Charlottesville 22908, USA
    Endocrinology 139:4164-74. 1998
    ....
  2. ncbi request reprint The role of mitogen-activated protein (MAP) kinase in breast cancer
    Richard J Santen
    Department of Medicine, Division of Endocrinology, University of Virginia Health System, P O Box 800379, Charlottesville, VA 22908, USA
    J Steroid Biochem Mol Biol 80:239-56. 2002
    ..Additional studies are now needed to determine the precise relationship between MAP kinase activation and tumor proliferation, apoptosis, and degree of invasiveness as well as on disease free and overall survival...
  3. ncbi request reprint EphA2 overexpression decreases estrogen dependence and tamoxifen sensitivity
    Ming Lu
    Department of Basic Medical Sciences, Purdue University Cancer Center, West Lafayette, Indiana 47907, USA
    Cancer Res 63:3425-9. 2003
    ..These results have important implications for understanding the molecular basis underlying estrogen dependence and provide further evidence that EphA2 may provide a much-needed therapeutic target for breast cancer...
  4. ncbi request reprint Imatinib mesylate (Gleevec) inhibits ovarian cancer cell growth through a mechanism dependent on platelet-derived growth factor receptor alpha and Akt inactivation
    Daniela Matei
    Department of Medicine, Walther Oncology Center, Indiana University Cancer Center, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
    Clin Cancer Res 10:681-90. 2004
    ....
  5. ncbi request reprint HOXB13 homeodomain protein suppresses the growth of prostate cancer cells by the negative regulation of T-cell factor 4
    Chaeyong Jung
    Department of Urology, Walther Oncology Center, Indiana University, Indianapolis, Indiana 46202, USA
    Cancer Res 64:3046-51. 2004
    ..This observation will provide valuable insight into the molecular basis of prostate tumorigenesis...
  6. ncbi request reprint Targeting prostate cancer with conditionally replicative adenovirus using PSMA enhancer
    Sang Jin Lee
    Department of Urology, Indiana University, Indianapolis, IN 46202, USA
    Mol Ther 10:1051-8. 2004
    ..These studies suggest that PSME-driven replication-competent adenovirus may be a new therapeutic modality for prostate cancer patients after hormone ablation therapy...
  7. ncbi request reprint Transcriptional targeting modalities in breast cancer gene therapy using adenovirus vectors controlled by alpha-lactalbumin promoter
    Xiong Li
    Department of Urology, Indiana University School of Medicine, Indianapolis, IN 46202, USA
    Mol Cancer Ther 4:1850-9. 2005
    ....
  8. ncbi request reprint Anti-tumor efficacy of a transcriptional replication-competent adenovirus, Ad-OC-E1a, for osteosarcoma pulmonary metastasis
    Xiong Li
    Department of Urology, Indiana University School of Medicine, Indianapolis, IN 46202, USA
    J Gene Med 8:679-89. 2006
    ..OC is also known to express in cell lines with bone metastasis feathers. Gene therapy strategies with the OC promoter directing the replication of adenovirus in a tumor-specific manner are a potential modality for OSPM therapy...